$8.39
arrow_drop_down0.59%Key Stats | |
---|---|
Open | $8.45 |
Prev. Close | $8.44 |
EPS | -1.09 |
Dividend | Non-Dividend |
Next Earnings Date | - |
Dividend Yield % | - |
PE Ratio | - |
LOW | HIGH | |
---|---|---|
Day Range | 8.13 | 8.53 |
52 Week Range | 1.99 | 11.31 |
Ratios | |
---|---|
EPS | -1.09 |
Don't miss out on the opportunity to stay ahead in the ever-changing world of finance.
Period: Next 12 Months
•Adding the right stocks to your watchlist can provide valuable insights and opportunities for strategic decision-making.
Deep Dive Into Ocular Therapeutix Stock: Analyst Perspectives (6 Ratings)
Ocular Therapeutix™ Highlights Exceptional AXPAXLI™ SOL-1 Enrollment and Plans for Repeat Dosing Study (SOL-R) in wet AMD at Investor Day, Along with Positive 48-week Data from HELIOS NPDR Study
Ocular Therapeutix® to Host Investor Day on June 13, 2024
Ocular Therapeutix® Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
Ocular Therapeutix Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
Ocular Therapeutix™ to Present at Two Upcoming Investor Conferences